Hologic, Inc. 0J5Q.L Stock
Hologic, Inc. Price Chart
Hologic, Inc. 0J5Q.L Financial and Trading Overview
Hologic, Inc. stock price | 72.75 USD |
Previous Close | 79.21 USD |
Open | 0 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 86.55 USD |
Volume | 1.95K USD |
Avg. Volume | 1.47K USD |
Market Cap | 214.59M USD |
Beta (5Y Monthly) | 1.012676 |
PE Ratio (TTM) | 0.13240297 |
EPS (TTM) | 6.06 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0J5Q.L Valuation Measures
Enterprise Value | 19.73B USD |
Trailing P/E | 0.13240297 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.05289884 |
Price/Book (mrq) | 3.7222583 |
Enterprise Value/Revenue | 4.864 |
Enterprise Value/EBITDA | 14.896 |
Trading Information
Hologic, Inc. Stock Price History
Beta (5Y Monthly) | 1.012676 |
52-Week Change | 17.73% |
S&P500 52-Week Change | 20.43% |
52 Week High | 86.55 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 81.65 USD |
200-Day Moving Average | 76.07 USD |
0J5Q.L Share Statistics
Avg. Volume (3 month) | 1.47K USD |
Avg. Daily Volume (10-Days) | 523 USD |
Shares Outstanding | 289.21M |
Float | 244.09M |
Short Ratio | N/A |
% Held by Insiders | 0.73% |
% Held by Institutions | 100.05% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | September 24, 2022 |
Most Recent Quarter (mrq) | April 1, 2023 |
Next Fiscal Year End | September 24, 2023 |
Profitability
Profit Margin | 18.56% |
Operating Margin (ttm) | 23.21% |
Gross Margin | 62.65% |
EBITDA Margin | 32.65% |
Management Effectiveness
Return on Assets (ttm) | 6.20% |
Return on Equity (ttm) | 14.91% |
Income Statement
Revenue (ttm) | 4.06B USD |
Revenue Per Share (ttm) | 16.29 USD |
Quarterly Revenue Growth (yoy) | -28.49% |
Gross Profit (ttm) | 3.31B USD |
EBITDA | 1.32B USD |
Net Income Avi to Common (ttm) | 753M USD |
Diluted EPS (ttm) | 6.055 |
Quarterly Earnings Growth (yoy) | -52.10% |
Balance Sheet
Total Cash (mrq) | 2.61B USD |
Total Cash Per Share (mrq) | 10.6 USD |
Total Debt (mrq) | 2.84B USD |
Total Debt/Equity (mrq) | 53.66 USD |
Current Ratio (mrq) | 4.41 |
Book Value Per Share (mrq) | 21.538 |
Cash Flow Statement
Operating Cash Flow (ttm) | 959M USD |
Levered Free Cash Flow (ttm) | 726.48M USD |
Profile of Hologic, Inc.
Country | United Kingdom |
State | MA |
City | Marlborough |
Address | 250 Campus Drive |
ZIP | 01752 |
Phone | 508 263 2900 |
Website | https://www.hologic.com |
Industry | |
Sector(s) | |
Full Time Employees | 6944 |
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Q&A For Hologic, Inc. Stock
What is a current 0J5Q.L stock price?
Hologic, Inc. 0J5Q.L stock price today per share is 72.75 USD.
How to purchase Hologic, Inc. stock?
You can buy 0J5Q.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hologic, Inc.?
The stock symbol or ticker of Hologic, Inc. is 0J5Q.L.
How many shares does Hologic, Inc. have in circulation?
The max supply of Hologic, Inc. shares is 2.68M.
What is Hologic, Inc. Price to Earnings Ratio (PE Ratio)?
Hologic, Inc. PE Ratio is 0.12015541 now.
What was Hologic, Inc. earnings per share over the trailing 12 months (TTM)?
Hologic, Inc. EPS is 6.06 USD over the trailing 12 months.